Overview

Repeated Dose IV Baclofen Safety/Bioequivalence Study

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify a suitable dosing regimen of IV baclofen to serve as a temporary substitute for an oral regimen.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Allaysis, LLC
Collaborators:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Baclofen